SE7801089L - Imidazolderivat - Google Patents

Imidazolderivat

Info

Publication number
SE7801089L
SE7801089L SE7801089A SE7801089A SE7801089L SE 7801089 L SE7801089 L SE 7801089L SE 7801089 A SE7801089 A SE 7801089A SE 7801089 A SE7801089 A SE 7801089A SE 7801089 L SE7801089 L SE 7801089L
Authority
SE
Sweden
Prior art keywords
imidazol derivative
imidazol
derivative
Prior art date
Application number
SE7801089A
Other languages
English (en)
Other versions
SE439633B (sv
Inventor
J Heeres
L J J Backx
J H Mostmans
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of SE7801089L publication Critical patent/SE7801089L/sv
Publication of SE439633B publication Critical patent/SE439633B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/84—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24—Radicals substituted by singly bound oxygen or sulfur atoms esterified

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7801089A 1977-01-31 1978-01-30 Forfarande for framstellning av heterocykliska derivat av 1-(1,3-dioxolan-2-ylmetyl)-1h-imidazoler och 1h-1,2,4-triazoler SE439633B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76426577A 1977-01-31 1977-01-31
US05/853,726 US4160841A (en) 1977-01-31 1977-11-21 Heterocyclic derivatives of 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles

Publications (2)

Publication Number Publication Date
SE7801089L true SE7801089L (sv) 1978-08-01
SE439633B SE439633B (sv) 1985-06-24

Family

ID=27117425

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7801089A SE439633B (sv) 1977-01-31 1978-01-30 Forfarande for framstellning av heterocykliska derivat av 1-(1,3-dioxolan-2-ylmetyl)-1h-imidazoler och 1h-1,2,4-triazoler

Country Status (24)

Country Link
US (1) US4160841A (sv)
JP (1) JPS53101377A (sv)
AT (1) AT367419B (sv)
AU (1) AU511358B2 (sv)
BE (1) BE863437A (sv)
CA (1) CA1117534A (sv)
CH (1) CH644117A5 (sv)
DE (1) DE2803870A1 (sv)
DK (1) DK42778A (sv)
ES (1) ES466483A1 (sv)
FI (1) FI62836C (sv)
FR (1) FR2378780A1 (sv)
GB (1) GB1594860A (sv)
GR (1) GR66115B (sv)
HU (1) HU177458B (sv)
IE (1) IE46055B1 (sv)
IL (1) IL53924A (sv)
IT (1) IT1105153B (sv)
LU (1) LU78969A1 (sv)
NL (1) NL7801088A (sv)
PH (1) PH13955A (sv)
PT (1) PT67599B (sv)
SE (1) SE439633B (sv)
SU (1) SU703020A3 (sv)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4144346A (en) * 1977-01-31 1979-03-13 Janssen Pharmaceutica N.V. Novel 1-(1,3-dioxolan-2-ylmethyl)-1H-imidazoles
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
DE2967202D1 (en) * 1978-07-03 1984-10-11 Janssen Pharmaceutica Nv Derivatives of (4-(piperazin-1-yl-phenyloxymethyl)-1.3-dioxolan-2-ylmethyl)-1h-imidazoles and -1h-1.2.4-triazoles, their preparation and use as fungicides and bactericides
US4287195A (en) * 1978-07-14 1981-09-01 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
US4338327A (en) * 1978-10-06 1982-07-06 Janssen Pharmaceutica, N.V. Substituted 1-(2-aryl-1,3-dioxolan-2-ylmethyl)-1H-1,2,4-triazoles
US4402957A (en) * 1979-04-04 1983-09-06 Janssen Pharmaceutica N.V. Heterocyclic derivatives of [4-(piperazin-1-ylphenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
DE3039087A1 (de) * 1980-10-16 1982-05-19 Hoechst Ag, 6000 Frankfurt 1-(1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
DE3104380A1 (de) * 1981-02-07 1982-08-19 Bayer Ag, 5090 Leverkusen Antimikrobielle mittel
DE3104311A1 (de) * 1981-02-07 1982-08-19 Bayer Ag, 5090 Leverkusen 2-azolylmethyl-1,3-dioxolan- und -dioxan-derivate, verfahren zu ihrer herstellung und ihre verwendung als fungizide
US4456605A (en) * 1981-05-07 1984-06-26 Janssen Pharmaceutica N.V. Heterocyclic derivatives of [4-(piperazin-1-yl-phenyloxymethyl)-1,3-dioxolan-2-ylmethyl]-1H-imidazoles and 1H-1,2,4-triazoles
JPS59139380A (ja) * 1983-01-28 1984-08-10 Yoshiki Hamada １，３―ジオキソランアシラート誘導体及びその製造法
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
EP0121081B1 (de) * 1983-03-03 1991-01-30 BASF Aktiengesellschaft Azolylmethylcycloalkane, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
DE3308554A1 (de) * 1983-03-10 1984-09-13 Hoechst Ag, 6230 Frankfurt 1-/1,3-dioxolan-2-ylmethyl)-azole, ihre salze, verfahren zu ihrer herstellung und ihre verwendung
JPS59205366A (ja) * 1983-04-12 1984-11-20 スミスクライン・ベツクマン・コ−ポレイシヨン ド−パミン−β−ヒドロキシラ−ゼ抑制物質
US6730796B2 (en) 2000-10-16 2004-05-04 Chugai Seiyaku Kabushiki Kaisha Process for preparation of N-substituted 2-sulfanylimidazoles
US20050074494A1 (en) * 2003-10-06 2005-04-07 Xiu-Xiu Cheng Itraconazole immediate release formulation
US8629285B2 (en) * 2005-08-18 2014-01-14 Synta Pharmaceuticals Corp. Imidazole compounds that modulate HSP90 activity
KR100793693B1 (ko) 2006-05-09 2008-01-10 (주)유케이케미팜 이트라코나졸의 개선된 제조 방법
KR102122569B1 (ko) * 2012-12-25 2020-06-15 후아 메디슨 1-([1,3]디옥솔란-4-일메틸)-1η-피라졸-3-일아민을 제조하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3575999A (en) * 1968-08-19 1971-04-20 Janssen Pharmaceutica Nv Ketal derivatives of imidazole
US3936470A (en) * 1975-01-27 1976-02-03 Janssen Pharmaceutica N.V. 1,3-Dioxolan-2-ylmethylimidazoles
US4101664A (en) * 1975-10-06 1978-07-18 Janssen Pharmaceutica N.V. 1-(2-Ar-4-aryloxymethyl-1,3-dioxolan-2-ylmethyl)-imidazoles
CA1065873A (en) * 1975-01-27 1979-11-06 Janssen Pharmaceutica Naamloze Vennootschap Imidazole derivatives

Also Published As

Publication number Publication date
PH13955A (en) 1980-11-12
AU3285278A (en) 1979-08-09
ATA63778A (de) 1981-11-15
US4160841A (en) 1979-07-10
HU177458B (en) 1981-10-28
GB1594860A (en) 1981-08-05
AU511358B2 (en) 1980-08-14
FR2378780A1 (fr) 1978-08-25
IE780196L (en) 1978-07-31
IT1105153B (it) 1985-10-28
SE439633B (sv) 1985-06-24
SU703020A3 (ru) 1979-12-05
CA1117534A (en) 1982-02-02
JPS6339595B2 (sv) 1988-08-05
IL53924A (en) 1981-12-31
IE46055B1 (en) 1983-02-09
FI62836C (fi) 1983-03-10
JPS53101377A (en) 1978-09-04
IL53924A0 (en) 1978-04-30
GR66115B (sv) 1981-01-16
FI62836B (fi) 1982-11-30
LU78969A1 (fr) 1978-06-21
DE2803870A1 (de) 1978-08-03
BE863437A (nl) 1978-07-31
IT7847838A0 (it) 1978-01-30
FR2378780B1 (sv) 1984-11-30
PT67599A (en) 1978-02-01
FI780293A (fi) 1978-08-01
CH644117A5 (de) 1984-07-13
DK42778A (da) 1978-08-01
NL7801088A (nl) 1978-08-02
PT67599B (en) 1980-01-14
ES466483A1 (es) 1979-06-01
AT367419B (de) 1982-07-12

Similar Documents

Publication Publication Date Title
SE7809792L (sv) Imidazolderivat
SE7805879L (sv) Mevalonolaktonderivat
PT68458A (pt) Triphenylalkene derivatives
FI783407A (fi) Anordning foer framstaellning av bandformad fiberprodukt
SE7803626L (sv) Hydantoin
SE7803475L (sv) Hallare for pasar
SE7801466L (sv) Imidazolderivat
SE7803476L (sv) Hallare for pasar
SE7711581L (sv) Xantin-derivat
FI782296A (fi) Anordning foer behandling av ytan av oregelbundna konturer uppvisande kroppar
SE7801089L (sv) Imidazolderivat
DK543178A (da) Thiodydantoinderivater
SE7804446L (sv) Tienamycinderivat
SE7803057L (sv) Bensimidazolderivat
SE7712754L (sv) Bervegg for rorslingor
SE7805260L (sv) Alkylendiaminderivat
SE7800982L (sv) Meta-sulfonamido-bensamid-derivat
SE7801997L (sv) Dipeptidderivat
SE7802394L (sv) Imidazolderivat
SE7812411L (sv) Instas for eldstad
SE7805140L (sv) Bensimidazolderivat
BE869020A (fr) Uit meerdere panelen bestaande schuifdeuren
FI783393A (fi) 2-imino-imidazolidinderivat
FI780344A (fi) Oxadiazolopyrimidinderivat
FI780343A (fi) Oxadiazolopyrimidinderivat

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7801089-9

Effective date: 19910805

Format of ref document f/p: F